Teriflunomide Tablets 14 mg Teru-MS 14 Trademark (Class 5) — Registered Status & Details
Source: Indian Trademark Registry (ipindia.gov.in) · IP India record as of 25/05/2026 · Indexed 2026-05-25 · Last updated 25 May 2026
Trademark Fact Sheet
- Trademark (as filed)
- Teriflunomide Tablets 14 mg Teru-MS 14DEVICE
- Application No.
- 5376535
- Filed
- 19/03/2022
- Status
- Registered
- Class(es)
- Class 5
- TM Office
- CHENNAI
- Owner's state
- Telangana
- TM type
- DEVICE
- Valid upto
- 19/03/2032
- Published in Journal
- Published in Journal No. : 2215-0 Dated : 30/06/2025
Goods & Services
PHARMACEUTICAL PRODUCT
Owner
- Name
- MSN LABORATORIES PRIVATE LIMITED Body Incorporate9 trademarks filed under this owner
- Address
- *****, HYDERABD 500018
- *********nta(at)gmail.com
- State
- Telangana
Other trademarks by this owner
8 other marks filed under MSN LABORATORIES PRIVATE LIMITED Body Incorporate. Live marks link to their full details.
| Wordmark | App No. | Class | Status |
|---|---|---|---|
| CANGRELOR FOR INJECTION CANREAL TM #7890751 · Filed 29/07/2026 | 7890751 | Class 5 | Send To Vienna Codification |
| CANREAL TM #7890750 · Filed 29/07/2026 | 7890750 | Class 5 | Formalities Chk Pass |
| MSN ELUXANEXT TM #7869724 · Filed 20/07/2026 | 7869724 | Class 5 | Formalities Chk Pass |
| Tucaone TM #6955205 · Filed 14/04/2025 | 6955205 | Class 5 | Formalities Chk Pass |
| Elgoliz TM #5676814 · Filed 10/11/2022 | 5676814 | Class 5 | Registered |
| ABIRATERONE ACETATE TABLETS IP 250 mg ABURA TM #5118432 · Filed 04/09/2021 | 5118432 | Class 5 | Registered |
| Abiraterone Acetate IP Tablets 500 mg Abura-500 TM #5118428 · Filed 04/09/2021 | 5118428 | Class 5 | Registered |
| MSN Rebopag TM #5117583 · Filed 04/09/2021 | 5117583 | Class 5 | Registered |
Application Timeline
Uploaded Documents
7 documents filed with the Trade Marks Registry for this application.
| # | Document | Date |
|---|---|---|
| 1 | TM-A(TRADE MARKS APPLICATION) | 19 Mar 2022 |
| 2 | Reply to Exam Report (MIS-R) | 30 May 2022 |
| 3 | Documents in support of Show cause Hearing (SCH) | 20 Feb 2024 |
| 4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 20 Feb 2024 |
| 5 | Documents in support of Show cause Hearing (SCH) | 15 Oct 2024 |
| 6 | Journal Copy | 3 Jul 2025 |
| 7 | Certificate | 14 Nov 2025 |
Correspondence and Notices
14 notices issued by the Registry on this application.
| # | Subject | Corres. No. | Date |
|---|---|---|---|
| 1 | EXAMINATION REPORT | 13501657 | 17 May 2022 |
| 2 | Hearing Notice (Show Cause) | 17254406 | 30 Jan 2024 |
| 3 | Hearing Notice (Show Cause) | 18140919 | 10 May 2024 |
| 4 | Adjourned Notice | 18339742 | 19 Jun 2024 |
| 5 | Hearing Notice (Show Cause) | 18835158 | 11 Sep 2024 |
| 6 | Adjourned Notice | 19005014 | 16 Oct 2024 |
| 7 | Hearing Notice (Show Cause) | 19419050 | 1 Jan 2025 |
| 8 | Adjourned Notice | 19610753 | 30 Jan 2025 |
| 9 | Hearing Notice (Show Cause) | 19666205 | 7 Feb 2025 |
| 10 | Adjourned Notice | 19918177 | 20 Mar 2025 |
| 11 | Hearing Notice (Show Cause) | 19954325 | 26 Mar 2025 |
| 12 | Adjourned Notice | 20122883 | 28 Apr 2025 |
| 13 | Hearing Notice for Application No. 5376535 | 20250583 | 20 May 2025 |
| 14 | Tribunal Accepted Notice for : 5376535 | 20445133 | 23 Jun 2025 |
Filing claims & diligence
- First use claim
- 07/06/2018
- Filing mode
- e-Filing
- Category
- TRADE MARK
What does this status mean?
Teriflunomide Tablets 14 mg Teru-MS 14 is a registered trademark in Class 5. The owner holds exclusive rights to use this mark for PHARMACEUTICAL PRODUCT and can renew it to keep the protection in force. Planning a similar mark in Class 5? It may be blocked — check availability before you file.
Frequently asked questions
The trademark Teriflunomide Tablets 14 mg Teru-MS 14 (Application No. 5376535) is owned by (1) MSN LABORATORIES, as recorded in the Indian Trademark Registry. Trademark ownership in India is determined by the Trade Marks Act, 1999 and the Trade Marks Rules, 2017.
The current status of Teriflunomide Tablets 14 mg Teru-MS 14 is "Registered". It was filed on 19/03/2022 at CHENNAI in Class 5. Status may change over time as the application moves through examination, publication, opposition and registration stages.
Teriflunomide Tablets 14 mg Teru-MS 14 is filed in Class 5, covering: PHARMACEUTICAL PRODUCT.
Teriflunomide Tablets 14 mg Teru-MS 14 covers: PHARMACEUTICAL PRODUCT.
The exact word "Teriflunomide Tablets 14 mg Teru-MS 14" is already on record at the Indian Trademark Registry under Application No. 5376535. If you intend to use a similar mark for similar goods or services, you should conduct a comprehensive availability search and consult a trademark attorney before filing. Registerkaro offers a free availability check followed by professional filing.
Teriflunomide Tablets 14 mg Teru-MS 14 is valid up to 19/03/2032. Indian trademarks are valid for 10 years from the date of registration and can be renewed indefinitely in 10-year blocks.
If Teriflunomide Tablets 14 mg Teru-MS 14 is in the "Advertised before Acceptance" or "Accepted & Advertised" stage, you have a 4-month window from publication in the Trade Marks Journal to file an opposition (Form TM-O) at the same Trade Marks Registry office. Grounds typically include prior rights, descriptiveness or bad faith. Registerkaro can prepare and file a Notice of Opposition for you.
— Public Notice —
Protect a mark like "Teriflunomide Tablets 14 mg Teru-MS 14"
Free availability check, attorney drafting, and end-to-end TM-A filing through Registerkaro. Pick the plan that fits — government fee additional.
For individuals or companies who just want to file a trademark.
- Help choosing the right trademark class
- Drafting & Filing by TM Expert + Power of Attorney form
- Acknowledgement Receipt
- TM usage guide